A phase I study of temozolomide and everolimus (RAD001) in patients with newly diagnosed and progressive glioblastoma either receiving or not receiving enzyme-inducing anticonvulsants: An NCIC CTG study

Authors
Publication date
1 December 2012
Publisher
'Springer Science and Business Media LLC'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      University of Queensland eSpace

      redirect
      oaioai:espace.library.uq.edu.au:U...
      Last time updated on 30/04/2018